A detailed history of Squarepoint Ops LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Squarepoint Ops LLC holds 324,699 shares of BNTX stock, worth $38.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
324,699
Previous 278,672 16.52%
Holding current value
$38.1 Million
Previous $22.4 Million 72.21%
% of portfolio
0.06%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$78.36 - $124.66 $3.61 Million - $5.74 Million
46,027 Added 16.52%
324,699 $38.6 Million
Q2 2024

Aug 14, 2024

SELL
$80.36 - $102.87 $4.41 Million - $5.65 Million
-54,939 Reduced 16.47%
278,672 $22.4 Million
Q1 2024

May 15, 2024

BUY
$88.96 - $112.35 $1.54 Million - $1.95 Million
17,312 Added 5.47%
333,611 $30.8 Million
Q4 2023

Feb 14, 2024

BUY
$90.91 - $112.75 $24.5 Million - $30.4 Million
269,845 Added 580.89%
316,299 $33.4 Million
Q2 2023

Aug 14, 2023

BUY
$102.58 - $129.66 $2.33 Million - $2.94 Million
22,699 Added 95.55%
46,454 $5.01 Million
Q1 2023

May 15, 2023

BUY
$122.57 - $153.67 $987,791 - $1.24 Million
8,059 Added 51.34%
23,755 $2.96 Million
Q4 2022

Feb 14, 2023

BUY
$118.43 - $186.05 $1.86 Million - $2.92 Million
15,696 New
15,696 $2.36 Million
Q2 2022

Aug 15, 2022

BUY
$123.25 - $186.24 $1.14 Million - $1.72 Million
9,253 Added 44.38%
30,104 $4.49 Million
Q1 2022

May 16, 2022

BUY
$126.25 - $231.85 $1.43 Million - $2.63 Million
11,356 Added 119.6%
20,851 $3.56 Million
Q4 2021

Feb 14, 2022

SELL
$216.64 - $362.52 $974,446 - $1.63 Million
-4,498 Reduced 32.14%
9,495 $2.45 Million
Q3 2021

Nov 15, 2021

BUY
$205.93 - $447.23 $1.07 Million - $2.33 Million
5,214 Added 59.39%
13,993 $3.82 Million
Q2 2021

Aug 16, 2021

BUY
$113.32 - $241.49 $994,836 - $2.12 Million
8,779 New
8,779 $1.97 Million
Q1 2021

May 17, 2021

SELL
$85.73 - $119.5 $1.82 Million - $2.54 Million
-21,233 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$72.71 - $129.54 $907,711 - $1.62 Million
12,484 Added 142.69%
21,233 $1.73 Million
Q3 2020

Nov 16, 2020

BUY
$57.81 - $104.17 $204,763 - $368,970
3,542 Added 68.02%
8,749 $606,000
Q2 2020

Aug 14, 2020

BUY
$38.58 - $66.74 $200,886 - $347,515
5,207 New
5,207 $348,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.5B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.